Osso VR, the VR surgical training platform, today revealed it’s closed a $66 million Series C funding round, something the business states will be utilized to widen its VR surgical offering and hire more specialist skill.
The Series C round was led by Oak HC/FT, which consistsof involvement from Signalfire, GSR Ventures, Tiger Global Management and Kaiser Permanente Ventures.
This brings the business’s lifetime exterior financialinvestment to around $109 million, with its $27 million Series B gettinghere in July 2021.
Founded in late 2016 by UCLA and Harvard-trained orthopedic cosmeticsurgeon Justin Barad, MD, Osso VR’s surgical training tech supplies on-demand, academic experiences to cosmeticsurgeons with a focus on familiarizing them with emerging strategies and innovations. The business works with market leaders such as Johnson & Johnson, Stryker, Zimmer Biomet and Smith & Nephew.
More justrecently, Osso VR made strides throughout the COVID-19 pandemic because its VR training permits medical experts to findout and practice from a range. It supplies modules throughout a number of fields, consistingof orthopedics, endoscopy, and a host of interventional treatments.
The business has now grown to more than 150 staffmembers, and Osso VR states it prepares to grow “exponentially” over the next year.
“The future at Osso VR is exceptionally intense. Each action of the method, we’ve remained real to our objective to equalize healthcare and seen the results that our platform brings to surgical training and evaluation,” stated Barad. “This round of financialinvestment supports the next action of our journey to offer gainaccessto to all healthcare specialists. I couldn’t be more ecstatic to take this next action with such a talented, enthusiastic group.”